The University of Chicago Header Logo

Connection

Richard Quigg to Mice

This is a "connection" page, showing publications Richard Quigg has written about Mice.
Connection Strength

1.437
  1. Complement regulation in renal disease models. Semin Nephrol. 2013 Nov; 33(6):575-85.
    View in: PubMed
    Score: 0.043
  2. The C5a receptor has a key role in immune complex glomerulonephritis in complement factor H-deficient mice. Kidney Int. 2012 Nov; 82(9):961-8.
    View in: PubMed
    Score: 0.039
  3. Distinct roles for C3a and C5a in complement-induced tubulointerstitial injury. Kidney Int. 2011 Sep; 80(5):524-34.
    View in: PubMed
    Score: 0.036
  4. Complement factor H deficiency accelerates development of lupus nephritis. J Am Soc Nephrol. 2011 Feb; 22(2):285-95.
    View in: PubMed
    Score: 0.035
  5. Abnormal immune complex processing and spontaneous glomerulonephritis in complement factor H-deficient mice with human complement receptor 1 on erythrocytes. J Immunol. 2010 Sep 15; 185(6):3759-67.
    View in: PubMed
    Score: 0.034
  6. Characterization of novel VEGF (vascular endothelial growth factor)-C splicing isoforms from mouse. Biochem J. 2010 May 27; 428(3):347-54.
    View in: PubMed
    Score: 0.034
  7. Chronic kidney disease induced in mice by reversible unilateral ureteral obstruction is dependent on genetic background. Am J Physiol Renal Physiol. 2010 Apr; 298(4):F1024-32.
    View in: PubMed
    Score: 0.033
  8. Renal FcRn reclaims albumin but facilitates elimination of IgG. J Am Soc Nephrol. 2009 Sep; 20(9):1941-52.
    View in: PubMed
    Score: 0.032
  9. Focal and segmental glomerulosclerosis induced in mice lacking decay-accelerating factor in T cells. J Clin Invest. 2009 May; 119(5):1264-74.
    View in: PubMed
    Score: 0.031
  10. Mesangial cell complement receptor 1-related protein y limits complement-dependent neutrophil accumulation in immune complex glomerulonephritis. Immunology. 2009 Sep; 128(1 Suppl):e895-904.
    View in: PubMed
    Score: 0.031
  11. MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy. FASEB J. 2008 Dec; 22(12):4126-35.
    View in: PubMed
    Score: 0.030
  12. Inhibition of NF-kappaB-dependent Bcl-xL expression by clusterin promotes albumin-induced tubular cell apoptosis. Kidney Int. 2008 Mar; 73(5):567-77.
    View in: PubMed
    Score: 0.028
  13. Alteration in kidney glucose and amino acids are implicated in renal pathology in MRL/lpr mice. Biochim Biophys Acta. 2007 Oct; 1772(10):1143-9.
    View in: PubMed
    Score: 0.028
  14. TNF is a key mediator of septic encephalopathy acting through its receptor, TNF receptor-1. Neurochem Int. 2008 Feb; 52(3):447-56.
    View in: PubMed
    Score: 0.028
  15. Absence of functional alternative complement pathway alleviates lupus cerebritis. Eur J Immunol. 2007 Jun; 37(6):1691-701.
    View in: PubMed
    Score: 0.027
  16. Mouse podocyte complement factor H: the functional analog to human complement receptor 1. J Am Soc Nephrol. 2007 Apr; 18(4):1157-66.
    View in: PubMed
    Score: 0.027
  17. Decay-accelerating factor but not CD59 limits experimental immune-complex glomerulonephritis. Lab Invest. 2007 Apr; 87(4):357-64.
    View in: PubMed
    Score: 0.027
  18. Unrestricted C3 activation occurs in Crry-deficient kidneys and rapidly leads to chronic renal failure. J Am Soc Nephrol. 2007 Mar; 18(3):811-22.
    View in: PubMed
    Score: 0.027
  19. Systemic lupus erythematosus and the brain: what mice are telling us. Neurochem Int. 2007 Jan; 50(1):5-11.
    View in: PubMed
    Score: 0.026
  20. The simple design of complement factor H: Looks can be deceiving. Mol Immunol. 2007 Jan; 44(1-3):123-32.
    View in: PubMed
    Score: 0.026
  21. Altered vitamin D metabolism in type II diabetic mouse glomeruli may provide protection from diabetic nephropathy. Kidney Int. 2006 Sep; 70(5):882-91.
    View in: PubMed
    Score: 0.026
  22. Distinct and separable roles of the complement system in factor H-deficient bone marrow chimeric mice with immune complex disease. J Am Soc Nephrol. 2006 May; 17(5):1354-61.
    View in: PubMed
    Score: 0.025
  23. Complement-dependent apoptosis and inflammatory gene changes in murine lupus cerebritis. J Immunol. 2005 Dec 15; 175(12):8312-9.
    View in: PubMed
    Score: 0.025
  24. Signaling through up-regulated C3a receptor is key to the development of experimental lupus nephritis. J Immunol. 2005 Aug 01; 175(3):1947-55.
    View in: PubMed
    Score: 0.024
  25. C5a promotes development of experimental lupus nephritis which can be blocked with a specific receptor antagonist. Eur J Immunol. 2005 Aug; 35(8):2496-506.
    View in: PubMed
    Score: 0.024
  26. MRL/lpr mice have alterations in brain metabolism as shown with [1H-13C] NMR spectroscopy. Neurochem Int. 2005 Jul; 47(1-2):143-51.
    View in: PubMed
    Score: 0.024
  27. An integrated strategy for the optimization of microarray data interpretation. Gene Expr. 2005; 12(4-6):223-30.
    View in: PubMed
    Score: 0.023
  28. Complement factor h limits immune complex deposition and prevents inflammation and scarring in glomeruli of mice with chronic serum sickness. J Am Soc Nephrol. 2005 Jan; 16(1):52-7.
    View in: PubMed
    Score: 0.023
  29. Role of Toll-like receptor 4 in endotoxin-induced acute renal failure. J Immunol. 2004 Feb 15; 172(4):2629-35.
    View in: PubMed
    Score: 0.022
  30. Administration of the soluble complement inhibitor, Crry-Ig, reduces inflammation and aquaporin 4 expression in lupus cerebritis. Biochim Biophys Acta. 2003 Nov 20; 1639(3):169-76.
    View in: PubMed
    Score: 0.021
  31. Excessive matrix accumulation in the kidneys of MRL/lpr lupus mice is dependent on complement activation. J Am Soc Nephrol. 2003 Oct; 14(10):2516-25.
    View in: PubMed
    Score: 0.021
  32. Administration of a soluble recombinant complement C3 inhibitor protects against renal disease in MRL/lpr mice. J Am Soc Nephrol. 2003 Mar; 14(3):670-9.
    View in: PubMed
    Score: 0.020
  33. Prominent renal expression of a murine leukemia retrovirus in experimental systemic lupus erythematosus. J Am Soc Nephrol. 2002 Dec; 13(12):2869-77.
    View in: PubMed
    Score: 0.020
  34. Acute renal failure in endotoxemia is caused by TNF acting directly on TNF receptor-1 in kidney. J Immunol. 2002 Jun 01; 168(11):5817-23.
    View in: PubMed
    Score: 0.019
  35. Transgenic expression of a soluble complement inhibitor protects against renal disease and promotes survival in MRL/lpr mice. J Immunol. 2002 Apr 01; 168(7):3601-7.
    View in: PubMed
    Score: 0.019
  36. A complement-dependent model of thrombotic thrombocytopenic purpura induced by antibodies reactive with endothelial cells. Clin Immunol. 2002 Apr; 103(1):43-53.
    View in: PubMed
    Score: 0.019
  37. Injury in renal ischemia-reperfusion is independent from immunoglobulins and T lymphocytes. Am J Physiol Renal Physiol. 2002 Feb; 282(2):F352-7.
    View in: PubMed
    Score: 0.019
  38. Macrophage Depletion Reduces Disease Pathology in Factor H-Dependent Immune Complex-Mediated Glomerulonephritis. J Immunol Res. 2022; 2022:1737419.
    View in: PubMed
    Score: 0.019
  39. Inhibiting the complement system does not reduce injury in renal ischemia reperfusion. J Am Soc Nephrol. 2001 Jul; 12(7):1383-1390.
    View in: PubMed
    Score: 0.018
  40. Local complement factor H protects kidney endothelial cell structure and function. Kidney Int. 2021 10; 100(4):824-836.
    View in: PubMed
    Score: 0.018
  41. A protein with characteristics of factor H is present on rodent platelets and functions as the immune adherence receptor. J Biol Chem. 2001 Aug 24; 276(34):32129-35.
    View in: PubMed
    Score: 0.018
  42. Unconjugated p-cresol activates macrophage macropinocytosis leading to increased LDL uptake. JCI Insight. 2021 06 08; 6(11).
    View in: PubMed
    Score: 0.018
  43. Expression of a soluble complement inhibitor protects transgenic mice from antibody-induced acute renal failure. J Am Soc Nephrol. 2001 Jan; 12(1):71-79.
    View in: PubMed
    Score: 0.017
  44. Complement is activated in kidney by endotoxin but does not cause the ensuing acute renal failure. Kidney Int. 2000 Oct; 58(4):1580-7.
    View in: PubMed
    Score: 0.017
  45. Renal, central nervous system and pancreatic overexpression of recombinant soluble Crry in transgenic mice. A novel means of protection from complement-mediated injury. Immunopharmacology. 1999 May; 42(1-3):245-54.
    View in: PubMed
    Score: 0.016
  46. Transgenic mice overexpressing the complement inhibitor crry as a soluble protein are protected from antibody-induced glomerular injury. J Exp Med. 1998 Oct 05; 188(7):1321-31.
    View in: PubMed
    Score: 0.015
  47. Absence of complement factor H alters bone architecture and dynamics. Immunobiology. 2018 12; 223(12):761-771.
    View in: PubMed
    Score: 0.015
  48. Blockade of antibody-induced glomerulonephritis with Crry-Ig, a soluble murine complement inhibitor. J Immunol. 1998 May 01; 160(9):4553-60.
    View in: PubMed
    Score: 0.015
  49. Immune complex glomerulonephritis in C4- and C3-deficient mice. Kidney Int. 1998 Feb; 53(2):320-30.
    View in: PubMed
    Score: 0.014
  50. Characterization of C3-binding proteins on mouse neutrophils and platelets. J Immunol. 1997 Sep 01; 159(5):2438-44.
    View in: PubMed
    Score: 0.014
  51. Characterization of C3 receptors on cultured rat glomerular endothelial cells. Kidney Int. 1997 Apr; 51(4):1124-32.
    View in: PubMed
    Score: 0.013
  52. C5a induces caspase-dependent apoptosis in brain vascular endothelial cells in experimental lupus. Immunology. 2016 08; 148(4):407-19.
    View in: PubMed
    Score: 0.013
  53. Loss of diacylglycerol kinase epsilon in mice causes endothelial distress and impairs glomerular Cox-2 and PGE2 production. Am J Physiol Renal Physiol. 2016 05 01; 310(9):F895-908.
    View in: PubMed
    Score: 0.012
  54. Characterization of rat complement receptors and regulatory proteins. CR2 and Crry are conserved, and the C3b receptor of neutrophils and platelets is distinct from CR1. J Immunol. 1995 Aug 01; 155(3):1481-8.
    View in: PubMed
    Score: 0.012
  55. Transcriptional profiling reveals that C5a alters microRNA in brain endothelial cells. Immunology. 2014 Nov; 143(3):363-73.
    View in: PubMed
    Score: 0.011
  56. Contrasting effects of systemic monocyte/macrophage and CD4+ T cell depletion in a reversible ureteral obstruction mouse model of chronic kidney disease. Clin Dev Immunol. 2013; 2013:836989.
    View in: PubMed
    Score: 0.011
  57. Curcumin alleviates immune-complex-mediated glomerulonephritis in factor-H-deficient mice. Immunology. 2013 Jul; 139(3):328-37.
    View in: PubMed
    Score: 0.010
  58. Curcumin aggravates CNS pathology in experimental systemic lupus erythematosus. Brain Res. 2013 Apr 04; 1504:85-96.
    View in: PubMed
    Score: 0.010
  59. DGKE variants cause a glomerular microangiopathy that mimics membranoproliferative GN. J Am Soc Nephrol. 2013 Feb; 24(3):377-84.
    View in: PubMed
    Score: 0.010
  60. Complement alternative pathway activation in the autologous phase of nephrotoxic serum nephritis. Am J Physiol Renal Physiol. 2012 Jun 15; 302(12):F1529-36.
    View in: PubMed
    Score: 0.010
  61. C5a/CD88 signaling alters blood-brain barrier integrity in lupus through nuclear factor-?B. J Neurochem. 2011 Dec; 119(5):1041-51.
    View in: PubMed
    Score: 0.009
  62. Inhibition of C5a receptor alleviates experimental CNS lupus. J Neuroimmunol. 2010 Apr 15; 221(1-2):46-52.
    View in: PubMed
    Score: 0.008
  63. C5a alters blood-brain barrier integrity in experimental lupus. FASEB J. 2010 Jun; 24(6):1682-8.
    View in: PubMed
    Score: 0.008
  64. C3aR inhibition reduces neurodegeneration in experimental lupus. Lupus. 2010 Jan; 19(1):73-82.
    View in: PubMed
    Score: 0.008
  65. Altered thymic selection by overexpressing cellular FLICE inhibitory protein in T cells causes lupus-like syndrome in a BALB/c but not C57BL/6 strain. Cell Death Differ. 2010 Mar; 17(3):522-33.
    View in: PubMed
    Score: 0.008
  66. Pathogenic natural antibodies recognizing annexin IV are required to develop intestinal ischemia-reperfusion injury. J Immunol. 2009 May 01; 182(9):5363-73.
    View in: PubMed
    Score: 0.008
  67. miR-17-92 cluster accelerates adipocyte differentiation by negatively regulating tumor-suppressor Rb2/p130. Proc Natl Acad Sci U S A. 2008 Feb 26; 105(8):2889-94.
    View in: PubMed
    Score: 0.007
  68. Renoprotective role of the vitamin D receptor in diabetic nephropathy. Kidney Int. 2008 Jan; 73(2):163-71.
    View in: PubMed
    Score: 0.007
  69. The role of the complement cascade in endotoxin-induced septic encephalopathy. Lab Invest. 2007 Dec; 87(12):1186-94.
    View in: PubMed
    Score: 0.007
  70. Negative regulation of CD40-mediated B cell responses by E3 ubiquitin ligase Casitas-B-lineage lymphoma protein-B. J Immunol. 2007 Oct 01; 179(7):4473-9.
    View in: PubMed
    Score: 0.007
  71. C3a is required for the production of CXC chemokines by tubular epithelial cells after renal ishemia/reperfusion. J Immunol. 2007 Feb 01; 178(3):1819-28.
    View in: PubMed
    Score: 0.007
  72. Acute renal failure in endotoxemia is dependent on caspase activation. J Am Soc Nephrol. 2004 Dec; 15(12):3093-102.
    View in: PubMed
    Score: 0.006
  73. Anti-diabetic effect of ginsenoside Re in ob/ob mice. Biochim Biophys Acta. 2005 Jun 10; 1740(3):319-25.
    View in: PubMed
    Score: 0.006
  74. Overexpression of complement inhibitor Crry does not prevent cryoglobulin-associated membranoproliferative glomerulonephritis. Kidney Int. 2004 Apr; 65(4):1214-23.
    View in: PubMed
    Score: 0.005
  75. CR1/CR2 deficiency alters IgG3 autoantibody production and IgA glomerular deposition in the MRL/lpr model of SLE. Autoimmunity. 2004 Mar; 37(2):111-23.
    View in: PubMed
    Score: 0.005
  76. The extended multidomain solution structures of the complement protein Crry and its chimeric conjugate Crry-Ig by scattering, analytical ultracentrifugation and constrained modelling: implications for function and therapy. J Mol Biol. 2003 Jun 06; 329(3):525-50.
    View in: PubMed
    Score: 0.005
  77. Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice. Proc Natl Acad Sci U S A. 2002 Aug 06; 99(16):10837-42.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.